World APS Day: Shining a Light on a Silent but Life-Threatening Autoimmune Disorder
The APS Foundation of America has shared an important update on their official X page in recognition of World APS Day. The post emphasizes the urgent need to raise awareness about Antiphospholipid Syndrome (APS)—an incurable, life-threatening autoimmune disorder that increases the risk of dangerous blood clots.
“Today is World APS Day, the global awareness campaign to raise awareness of Antiphospholipid Syndrome and its impact on our lives.
APS is an incurable, life-threatening autoimmune condition that causes the blood to clot.”
What is APS?
APS occurs when the immune system mistakenly produces antibodies that target phospholipids—critical components of cell membranes—leading to an increased risk of:
- Deep vein thrombosis (DVT)
- Pulmonary embolism
- Stroke
- Recurrent miscarriage
- Catastrophic multiorgan thrombosis in severe cases
Despite its profound clinical impact, APS remains underdiagnosed and misunderstood.
Hemostasis Today proudly joins the global movement to raise awareness, promote early diagnosis, and support ongoing research into this devastating condition. As we commemorate World APS Day, we stand with patients, families, and advocates in calling for increased education, improved testing, and more targeted therapies.
Let today be a reminder: Clots can kill, but knowledge can save lives.
Follow us on Hemostasis Today for expert insights, clinical updates, and patient stories throughout APS Awareness Month.
-
Dec 19, 2025, 13:30PPTA Europe’s Holiday Message: Wishing Health, Rest, and Renewal for 2026
-
Dec 19, 2025, 13:22If You Were Reading a “Bible for Blood Donation Volunteers,” What’s the ONE Thing That Must Be in It?
-
Dec 19, 2025, 12:52Julia Owens: Stroke Remains One of the World’s Leading Causes of Death and Disability
-
Dec 19, 2025, 12:03Pradeep Natarajan: Our New Genetic Study of Aortic Stenosis in ~3M
-
Dec 19, 2025, 11:47ESO Blog: Anna Gardin on Stroke Risk in the Era of Climate Extremes
-
Dec 19, 2025, 10:51Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
-
Dec 19, 2025, 10:08Camilla Lombardi Shares an EHC Nutrition Guide for People with Bleeding Disorders
-
Dec 19, 2025, 09:56Danny Hsu Shares The ”I-WISh” Study by Nichola Cooper on ITP
-
Dec 19, 2025, 09:39Paul Bolaji: A Landmark Achievement -The Historic 1st Nigerian Stroke Leaders’ Summit 2025